EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Implementation of a novel hybrid cord blood banking model within a private‐public‐partnership

Jessica Laue iD, L Mariotta, M Fluri, D Castelli, O Kürsteiner, G Nicoloso, A Etter, D Surbek

Transfusion · 2025

DOI: 10.1111/trf.18179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2025. Verfasst von Jessica Laue und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University Hospital of Bern, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Fetal Blood, Blood Banks, Public-Private Sector Partnerships, Blood Banking. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Umbilical cord blood (UCB) stem cells can be collected at birth, cryopreserved, and used for transplantation in hematopoietic diseases. Typically, these stem cells are stored in public banks for allogeneic use or in private depositories for potential future utilization by the family. A proposed third option, hybrid cord blood banking, combines elements of both public and private storage. This method allows family‐directed UCB to be HLA typed and included in the international registry, making it accessible to compatible patients globally. Study Design and Methods We describe the implementation of a novel hybrid cord blood banking model within a private–public partnership involving a university obstetric department, a national stem cell registry, and a private cord blood bank.

Results

From 2020 to 2023, 67 UCB units were collected for hybrid banking. Of these, 25 samples (37.3%) met the threshold of 120 grams for public banking. Before processing, 5 samples (7.5%) contained over 1.5 E9 total nucleated cells (TNC); after processing, 15 samples (22.46%) exceeded 1.0 E9 TNC. The viability margin of 85% was surpassed in 42 samples (62.7%). Cytofluorimetric analysis showed 36 samples (53.7%) had over 1.25 E6 CD34+ cells, with 63 samples (94.0%) exceeding 85% viability. For HLA typing and registry entry, 10 samples (14.9%) qualified for hybrid purposes, with one sample deemed unsuitable for processing.

Discussion

This study demonstrates the feasibility of the hybrid cord blood banking model within a private–public partnership. This new concept offers an extended option for parents to bank their child's cord blood stem cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fetal BloodBlood BanksPublic-Private Sector PartnershipsBlood BankingHumansCord Blood Stem Cell TransplantationFemaleBlood PreservationCryopreservation

Stichwörter der Autor:innen

hybrid cord blood bankingprivate–public Partnershipumbilical cord blood stem cells

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University Hospital of Bern, University of Bern, Bern, Switzerland.
  • Swiss Stem Cells Biotech (SSCB) AG, Zurich, Switzerland.
  • Blutspende SRK Schweiz, Swiss Blood Stem Cells (SBSC), Liebefeld, Switzerland.

ORCID-Profile: Jessica Laue

Zitieren

APA

Laue, J., Mariotta, L., Fluri, M., Castelli, D., Kürsteiner, O., Nicoloso, G., Etter, A., & Surbek, D. (2025). Implementation of a novel hybrid cord blood banking model within a private‐public‐partnership. Transfusion. https://doi.org/10.1111/trf.18179

Vancouver

Laue J, Mariotta L, Fluri M, Castelli D, Kürsteiner O, Nicoloso G, et al. Implementation of a novel hybrid cord blood banking model within a private‐public‐partnership. Transfusion. 2025. doi:10.1111/trf.18179

BibTeX
@article{Laue2025,
  author = {Laue, Jessica and Mariotta, L and Fluri, M and Castelli, D and Kürsteiner, O and Nicoloso, G and Etter, A and Surbek, D},
  title = {Implementation of a novel hybrid cord blood banking model within a private‐public‐partnership},
  journal = {Transfusion},
  year = {2025},
  doi = {10.1111/trf.18179}
}
Kostenlos starten →